SOUTH SAN FRANCISCO, Calif., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced Oxbryta® (voxelotor) tablets for oral suspension, a new dispersible, ...
Mylan’s subsidiary, Matrix Laboratories, announced that under the President’s Emergency Plan for AIDS Relief (PEPFAR), the FDA has approved water-dispersible zidovudine tablets, a generic version of ...
ViiV Healthcare announces US FDA approval of the first-ever dispersible tablet formulation of dolutegravir, Tivicay PD, a once-daily treatment for children living with HIV Dolutegravir is the first ...
Please provide your email address to receive an email when new articles are posted on . The FDA has approved dolutegravir tablets and dolutegravir tablets for oral suspension to treat HIV infection, ...
* VIIV HEALTHCARE -TIVICAY PD, EXTENDED INDICATION OF EXISTING TIVICAY 50MG FILM-COATED TABLET ARE CURRENTLY UNDER REVIEW BY EUROPEAN MEDICINES AGENCY * VIIV HEALTHCARE - DOLUTEGRAVIR IS 1ST INTEGRASE ...
The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. This medicine is new or being used differently. Please report side ...
Dispersible electrodes based on gold-coated magnetic nanoparticles modified with DNA can detect microRNA in unprocessed blood samples at extremely low concentrations and over a broad range – a first ...
Tribune Online on MSN
FULL LIST: NAFDAC releases 101 products withdrawn, suspended, cancelled in Nigeria
The National Agency for Food and Drug Administration and Control (NAFDAC) has released a list of 101 products that have been withdrawn, suspended, or cancelled in Nigeria. The agency said the affected ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback